The Story
Herbs of Gold Pain Relief PEA Forte contains 300mg of palmitoylethanolamide (PEA), or palmidrol, to relieve pain.
PEA is a fatty molecule that is produced in small amounts by the body in response to pain and inflammation. Herbs of Gold Pain Relief PEA Forte contains high-strength PEA, an analgesic that relieves the symptoms of mild arthritis and mild osteoarthritis, and reduces mild joint soreness, aches and pains. PEA can also be used by individuals who are seeking relief from mild nerve pain and neuralgia.
Pain Relief PEA Forte is formulated with PEA as Levagen®+, a clinically studied* form of PEA that uses LipiSperse® technology to enhance bioavailability. Clinical studies have shown that Levagen®+ is absorbed 1.75 times better than standard PEA**.
*Steels, E., Venkatesh, R., Steels, E., Vitetta, G., & Vitetta, L. (2019). A double-blind randomised placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27(3), 475-485.
**Briskey, D., Mallard, A. R., & Rao, A. (2020). Increased absorption of palmitoylethanolamide using a novel dispersion technology system (LipiSperse®). J Nutraceuticals Food Sci, 5(2), 3.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Description
Herbs of Gold Pain Relief PEA Forte contains 300mg of palmitoylethanolamide (PEA), or palmidrol, to relieve pain.
PEA is a fatty molecule that is produced in small amounts by the body in response to pain and inflammation. Herbs of Gold Pain Relief PEA Forte contains high-strength PEA, an analgesic that relieves the symptoms of mild arthritis and mild osteoarthritis, and reduces mild joint soreness, aches and pains. PEA can also be used by individuals who are seeking relief from mild nerve pain and neuralgia.
Pain Relief PEA Forte is formulated with PEA as Levagen®+, a clinically studied* form of PEA that uses LipiSperse® technology to enhance bioavailability. Clinical studies have shown that Levagen®+ is absorbed 1.75 times better than standard PEA**.
*Steels, E., Venkatesh, R., Steels, E., Vitetta, G., & Vitetta, L. (2019). A double-blind randomised placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology, 27(3), 475-485.
**Briskey, D., Mallard, A. R., & Rao, A. (2020). Increased absorption of palmitoylethanolamide using a novel dispersion technology system (LipiSperse®). J Nutraceuticals Food Sci, 5(2), 3.
